• Amesite entered an at-the-market equity offering agreement on July 17, 2026 to sell common stock from time to time.
• H.C. Wainwright will act as sales agent for up to the maximum amount allowed under the company’s effective Form S-3 shelf.
• Proceeds planning hinges on market conditions; sales may occur on Nasdaq at prevailing prices, subject to company-set size or price limits.
• The agent will receive a 3% commission on gross proceeds; expense reimbursement includes legal fees up to $50,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amesite Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-079637), on July 20, 2026, and is solely responsible for the information contained therein.